JAGSONPAL PHARMACEUTICALS LTD. Q3 FY25 Results
JAGSNPHARMQ3 FY25 ResultsAnnounced 22 Jan 2025, 06:13 pm| Metric | Value (₹ Cr) | vs Q2 FY25 |
|---|---|---|
| Revenue | 74.03 | 0.9% |
| Total Income | 76.35 | 0.0% |
| Expenditure | 60.86 | 0.2% |
| PBT | 38.67 | 151.6% |
| Net Profit | 31.99 | 179.2% |
| OPM | 45.50% | 30.58pp |
| NPM | 41.90% | 26.89pp |
| EPS | 4.74 | 10.5% |
Informational and educational content only. Not investment advice.